Atara Biotherapeutics, Inc. (ATRA) Operating income 2016–2025
Atara Biotherapeutics, Inc. (ATRA) annual operating income history from SEC filings — each fiscal year as reported.
$35.9MFY2025 · since FY2016: -$81.2M → $35.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.9M | +143.0% |
| FY2024 | -$83.4M | +69.8% |
| FY2023 | -$276.0M | +1.6% |
| FY2022 | -$280.5M | +17.6% |
| FY2021 | -$340.5M | -10.2% |
| FY2020 | -$309.1M | -4.5% |
| FY2019 | -$295.7M | -24.7% |
| FY2018 | -$237.1M | -95.1% |
| FY2017 | -$121.5M | -49.6% |
| FY2016 | -$81.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice